Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -99.4% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 6.9 | n/a |
Pr/Book | 1.8 |
Latest | F'cast | |
---|---|---|
Revenue | -14.6% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-21 | 133.66 | (166.00) | 23.00p | 30.3 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 198.60 | (83.41) | (11.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 169.67 | (149.77) | (19.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Holding(s) in Company | 21-Nov-2024 | 13:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 12-Nov-2024 | 16:00 | RNS |
Changes to the senior leadership team | 11-Nov-2024 | 07:00 | RNS |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
12-Nov-24 | Transfer From | Nick Keher | 0.000p | 105 | £0.00 |
12-Nov-24 | Buy | Nick Keher | 142.00p | 105 | £149.10 |
15-Oct-24 | Sell | Gurdial (Gordon) Sanghera | 141.66p | 1,993,571 | £2,824,112.62 |
Currency | UK Pounds |
Share Price | 122.80p |
Change Today | 0.40p |
% Change | 0.33 % |
52 Week High | 208.20 |
52 Week Low | 86.55 |
Volume | 1,112,467 |
Shares Issued | 954.11m |
Market Cap | £1,171.65m |
Beta | 1.28 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:37 | 183,613 @ 122.72p |
17:05 | 100 @ 122.80p |
16:29 | 135 @ 124.00p |
16:29 | 747 @ 123.90p |
16:29 | 469 @ 123.90p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research